Does BEVACIZUMAB Cause Mucosal inflammation? 853 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 853 reports of Mucosal inflammation have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 1.1% of all adverse event reports for BEVACIZUMAB.
853
Reports of Mucosal inflammation with BEVACIZUMAB
1.1%
of all BEVACIZUMAB reports
179
Deaths
315
Hospitalizations
How Dangerous Is Mucosal inflammation From BEVACIZUMAB?
Of the 853 reports, 179 (21.0%) resulted in death, 315 (36.9%) required hospitalization, and 54 (6.3%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which BEVACIZUMAB Alternatives Have Lower Mucosal inflammation Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ